Is routine chemical thromboprophylaxis after total hip replacement really necessary in a Japanese population?
Authors:
- 1 February 2011
- journal article
- research article
- Published by British Editorial Society of Bone & Joint Surgery in The Journal of Bone and Joint Surgery. British volume
- Vol. 93-B (2) , 251-256
Abstract
Prophylaxis against venous thromboembolism after elective total hip replacement is routinely recommended. Our preference has been to use mechanical prophylaxis without anticoagulant drugs. A randomised controlled trial was performed to evaluate whether the incidence of post-operative venous thromboembolism was reduced by using pharmacological anticoagulation with either fondaparinux or enoxaparin in addition to our prophylactic mechanical regimen. A total of 255 Japanese patients who underwent primary unilateral cementless total hip replacement were randomly assigned to one of three postoperative regimens, namely injection of placebo (saline), fondaparinux or enoxaparin. There were 85 patients in each group. All also received the same mechanical prophylaxis during and after the operation, regardless of their assigned group. The primary measurement of efficacy was the presence of a venous thromboembolic event by day 11, defined as deep-vein thrombosis detected by ultrasonography, documented symptomatic deep-vein thrombosis or documented symptomatic pulmonary embolism. The duration of follow-up was 12 weeks. The rate of venous thromboembolism was 7.2% with the placebo, 7.1% with fondaparinux and 6.0% with enoxaparin (p = 0.95 for the comparison of all three groups). Our study confirmed the effectiveness and safety of mechanical thromboprophylaxis without the use of anticoagulant drugs after total hip replacement in Japanese patients.Keywords
This publication has 27 references indexed in Scilit:
- Thrombosis Prevention After Total Hip ArthroplastyJournal of Bone and Joint Surgery, 2010
- Clinical Efficacy of Mechanical Thromboprophylaxis Without Anticoagulant Drugs for Elective Hip Surgery in an Asian PopulationThe Journal of Arthroplasty, 2009
- Oral rivaroxaban for the prevention of symptomatic venous thromboembolism after elective hip and knee replacementThe Journal of Bone and Joint Surgery. British volume, 2009
- Prevention of postoperative venous thromboembolism in Japanese patients undergoing total hip or knee arthroplasty: two randomized, double-blind, placebo-controlled studies with three dosage regimens of enoxaparinJournal of Orthopaedic Science, 2008
- Multimodal Thromboprophylaxis for Total Hip and Knee Arthroplasty Based on Risk AssessmentJournal of Bone and Joint Surgery, 2007
- Fondaparinux prevents venous thromboembolism after joint replacement surgery in Japanese patientsInternational Orthopaedics, 2007
- Prevention of Venous ThromboembolismChest, 2004
- Mechanical prophylaxis of deep-vein thrombosis after total hip replacementThe Journal of Bone and Joint Surgery. British volume, 2004
- Prevention and Treatment of Thromboembolic Disease: An OverviewTechniques in Orthopaedics, 2001
- Late Deep Venous Thrombosis and Delayed Weightbearing After Total Hip ArthroplastyClinical Orthopaedics and Related Research, 1999